You have 9 free searches left this month | to do more
Showing 1 - 25 of
579 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Soft Tissue Sarcoma
  • Sintilimab plus chemotherapy
  • Guangzhou, Guangdong, China
    Xing Zhang
2021-11-15
Nov 15, 2021
S
Recruiting
  • Soft Tissue Sarcoma
  • Apatinib Mesylate, doxorubicin, ifosfamide
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
2021-11-15
Nov 15, 2021
P
Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
2022-03-12
Mar 12, 2022
O
Recruiting
  • Soft Tissue Sarcoma
  • Bergen, Norway
  • +1 more
2021-09-10
Sep 10, 2021
S
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Durvalumab + doxorubicin + ifosfamide
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2020-11-30
Nov 30, 2020
P
Recruiting
  • Effect of Drug
  • +2 more
  • Beijing, Beijing, China
  • +1 more
2022-03-12
Mar 12, 2022
I
Completed
  • Soft Tissue Sarcoma
  • Patients starting a treatment with Doxorubicin and Ifosfamide
  • Bordeaux, France
  • +2 more
2021-01-11
Jan 11, 2021
S
Not yet recruiting
  • Extracranial Germ Cell Tumor, Pediatric
  • albumin-bound paclitaxel (nab-PTX), ifosfamide and cisplatin
  • (no location specified)
2020-10-06
Oct 6, 2020
J
Terminated
  • Sarcoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
2020-07-29
Jul 29, 2020
I
Recruiting
  • Non-metastatic Soft-tissue Sarcoma
  • Resectable
  • Bordeaux, France
  • +9 more
2022-02-01
Feb 1, 2022
S
Recruiting
  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2020-08-18
Aug 18, 2020
E
Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
2021-09-10
Sep 10, 2021
U
Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-29
Dec 29, 2021
M
Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-08-11
Aug 11, 2021
I
Completed
  • Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Center
2022-01-27
Jan 27, 2022
P
Withdrawn
  • Effect of Drugs
  • +2 more
  • Beijing, Beijing, China
    Lu Xie
2020-05-15
May 15, 2020
I
Active, not recruiting
  • Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
  • epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
  • +5 more
  • Candiolo, TO, Italy
  • +14 more
2021-11-15
Nov 15, 2021
U
Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
2022-02-02
Feb 2, 2022
T
Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • Brugge, Belgium
  • +21 more
2021-05-05
May 5, 2021
M
Active, not recruiting
  • Sarcoma
  • pegfilgrastim
  • +5 more
  • Baltimore, Maryland
  • +1 more
2022-03-25
Mar 25, 2022
S
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Seattle, Washington
    Swedish Cancer Institute
2021-03-01
Mar 1, 2021
I
Completed
  • Germ Cell Tumors
  • Angers, France
  • +11 more
2021-01-11
Jan 11, 2021
R
Active, not recruiting
  • CD20 Positive
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-10-11
Oct 11, 2021